Carson Allaria Wealth Management, Ltd. Vanda Pharmaceuticals Inc. Transaction History
Carson Allaria Wealth Management, Ltd.
- $169 Million
- Q4 2024
A detailed history of Carson Allaria Wealth Management, Ltd. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Carson Allaria Wealth Management, Ltd. holds 160 shares of VNDA stock, worth $707. This represents 0.0% of its overall portfolio holdings.
Number of Shares
160
Previous 160
-0.0%
Holding current value
$707
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding VNDA
# of Institutions
156Shares Held
45.2MCall Options Held
86.1KPut Options Held
40.8K-
Black Rock Inc. New York, NY8.14MShares$36 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.85MShares$17 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$15.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.49MShares$11 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.35MShares$10.4 Million0.85% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $250M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...